Innovative strategies to reduce heart failure hospitalizations: insights from the ESC heart failure congress 2026.

Heart failure (HF) represents a major burden on healthcare systems globally, driven by high rates of hospitalizations and readmissions, as well as prolonged length of stay (LOS). To address this, a wide range of innovative strategies have emerged and evolved in recent years. These approaches span a broad spectrum, ranging from novel routes of medication administration to digital health technologies such as telemonitoring, wearable devices, as well as implantable devices. Given the rapid expansion of available innovations, it can be challenging for clinicians to remain fully up to date with emerging tools and evidence. At the 2026 ESC Heart Failure Congress in Barcelona, Spain, global experts in the field highlighted different technologies and the key clinical trials supporting them. This review aims to synthesize the most recent innovative strategies aimed at reducing HF hospitalizations (HFH), as presented during the congress.